Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3817-3824. doi: 10.1016/j.bmcl.2017.06.054. Epub 2017 Jun 26.

Abstract

The NaV1.7 ion channel has garnered considerable attention as a target for the treatment of pain. Herein we detail the discovery and structure-activity relationships of a novel series of biaryl amides. Optimization led to the identification of several state-dependent, potent and metabolically stable inhibitors which demonstrated promising levels of selectivity over NaV1.5 and good rat pharmacokinetics. Compound 18, which demonstrated preferential inhibition of a slow inactivated state of NaV1.7, was advanced into a rat formalin study where upon reaching unbound drug levels several fold over the rat NaV1.7 IC50 it failed to demonstrate a robust reduction in nociceptive behavior.

Keywords: Na(V)1.5; Na(V)1.7; Pain; Sodium channel; State-dependent.

MeSH terms

  • Amides / chemical synthesis
  • Amides / chemistry
  • Amides / pharmacology*
  • Animals
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Humans
  • Mice
  • Molecular Structure
  • NAV1.7 Voltage-Gated Sodium Channel / metabolism*
  • Rats
  • Structure-Activity Relationship

Substances

  • Amides
  • NAV1.7 Voltage-Gated Sodium Channel
  • SCN9A protein, human
  • Scn9a protein, mouse
  • Scn9a protein, rat